CSACI Position Statement: Newer Generation H1-Antihistamines Are Safer Than First-Generation H1-Antihistamines and Should Be the First-Line Antihistamines for the Treatment of Allergic Rhinitis and Urticaria

Allergy, Asthma and Clinical Immunology - United Kingdom
doi 10.1186/s13223-019-0375-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antihistamines in Allergic Rhinitis - A Comparative Analysis

Medical Journal Armed Forces India
Medicine
2002English

Prophylactic Antihistamines

BMJ
1964English

Comparative Trial of Two Non-Sedative H1 Antihistamines, Terfenadine and Astemizole, for Hay Fever.

Thorax
PulmonaryRespiratory Medicine
1984English

Chloropyramine and Ranitidine as a Combination of H1 and H2- Antihistamines in the Additive Therapy of Anaphylaxis

Acta Medica Saliniana
Medicine
2020English

Antihistamines for the Common Cold

2011English

Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Efficacy and Safety of Methotrexate Add-On Therapy Versus Placebo for Patients With Chronic Spontaneous Urticaria Resistant to H1-Antihistamines: A Randomized, Controlled Trial

Journal of the American Academy of Dermatology
Dermatology
2020English

Antihistamines and Vascular Reactivity

American Journal of Physiology-Legacy Content
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy